year 16, Issue 1 (January - February 2022)                   Iran J Med Microbiol 2022, 16(1): 43-48 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sorkhi H, Shahhoseini F, Hajiahmadi M, Pournajaf A, Halaji M, Mohammadi M. A Nine-Year Follow-Up of Antimicrobial Resistance Profile in Children with Urinary Tract Infection in Northern Iran. Iran J Med Microbiol 2022; 16 (1) :43-48
URL: http://ijmm.ir/article-1-1427-en.html
1- Non-Communicable Pediatric Disease Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
2- Infectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
3- Non-Communicable Pediatric Disease Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran , Dr.mohamadi61@yahoo.com
Full-Text [PDF 459 kb]   (741 Downloads)     |   Abstract (HTML)  (2988 Views)
Full-Text:   (974 Views)
Introduction


Urinary tract infections (UTIs) are common infections in 3-5% female and 1% male children and are the commonest proven bacterial infection in febrile infants without localizing signs (1, 2). UTI is one of the main causes of hospitalization in children with significant complications and high healthcare costs (2, 3). Children with UTI may show non-specific symptoms, which can be challenging to diagnose. Therefore, timely diagnosis and proper treatment can reduce severe complications such as hypertension, renal scarring, pyelonephritis, and chronic kidney disease (CKD) (4, 5). A urine culture should be performed in children with fever of unknown origin (FUO) to rule out UTI (6). On the other hand, UTIs in children with vesicoureteral reflux (VUR) are very important in order not to cause renal scarring and CKD (7).
Long-term use of antibiotics is essential to prevent kidney damage in high-risk children. Proper treatment of UTIs has become challenging due to high resistance to frequently prescribed antibiotics (e.g., amino-penicillins, aminoglycosides, and quinolones) and the internationally increasing frequency of multidrug-resistant (MDR) organisms causing UTIs. Evidence has shown a high frequency of MDR in Gram-negative organisms (GNOs), which are the commonest cause of UTIs (7). Among the GNOs, uropathogenic Escherichia coli (UPEC) is the pathogen most frequently associated with UTIs. For example, resistance to ampicillin and SXT in the study of Vazouras et al. (2019) was reported to be more than 51% and 29%, respectively (8). The exact burden of antimicrobial resistance (AMR) in children in Iran is poorly understood, as few studies have been done in this area. The aims of this study were (i) to introduce antibiotic prescribing profiles for clinical and empirical treatments and (ii) to investigate the AMR rates of uropathogens isolated from hospitalized children with UTI in the Amirkola Children's hospital (Babol, north of Iran) over 9 years.


 

Materials and Methods

Study Design

This descriptive cross-sectional retrospective study was performed in 2019 and followed the trend of antibiotic resistance pattern over 9 years from 1994-1998 and 2013-2018. The Amirkola Children's hospital is a 110-registered bed hospital and is one of the most equipped teaching therapeutic centers affiliated to the Babol Medical University in the north of Iran. This work was approved (ethic code: IR.MUBABOL.HRI.-REC.1398.191) by the Research Ethics Committee of the Babol University of Medical Sciences, Iran.

Inclusion Criteria

Children from 1 month to 18 years of old with UTIs were included in the study. UTIs was defined based on the following criteria: (i) positive urine culture with pathogen growth ≥104 CFUmL-1 for catheter samples or suprapubic aspiration or ≥105 CFUmL-1 for clean-catch specimens; and (ii) pyuria (≥5 white blood cells per high-power field) in centrifuged urine OR positive dipstick (leukocyte esterase or nitrites) (9). Patients with incomplete records were excluded from the study.

Laboratory Methods

Erythrocyte sedimentation rate (ESR) was measured by the micro (capillary tube) laboratory method. The rate of RBC deposition per hour indicates a systemic inflammation and is more likely to indicate an upper UTI. The serum level of CRP was measured quan-titatively according to the manufacturer's instruction (Bionic, Iran). Antibiotic susceptibility pattern was performed using the Kirby–Bauer disk diffusion method on the Mueller-Hinton agar (Merck, Germany) recommended by the Clinical and Laboratory Standards Institute (CLSI) guideline. Commonly used antibiotics include, amikacin (AK; 30 µg), gentamicin (GM; 10 µg), nalidixic acid (NA; 30 µg), ceftizoxime (CZ; 30µg), ceftriaxone (CRO; 30 µg), trimethoprim-/sulfamethoxazle (SXT, 1.25/23.75 µg) nitrofurantoin (FT; 300µg), and ampicillin (AMP; 10 µg) (10).

Statistical Analyses

All statistical analyses were performed by SPSS 22 (SPSS Inc., Chicago, Ill., USA), and a P-value < 0.05 was considered significant. The results were analyzed using the Chi-square and Kruskal-Wallis tests, followed by residual analysis.

 
 

Results

A total of 253 children (n= 227; 89.7% of female, n=26; 10.3% of male) with a diagnosed UTI were followed during the study period. The mean age of patients included in the study was 38.8 ±40.9 months. UTI was diagnosed for the first time in 76.7% (n; 194/253) of children, and recurrent UTI (rUTI) was reported in 23.3% (n; 59/253) of cases.
The length of hospitalization was 9.42±3.13 days. The mean ±SD of CRP (mg/ dl), ESR (mm/ h) and WBC (cell/ mcl) were 75.61 ± 37.4, 61.59 ± 28.17 and 16187.63±6479.83, respectively. The mean level of WBC was 16187.63±6479.83 m/mm3. The highest and lowest CRP rate were 7 and 230 mg/dL, respectively. The ESR was in a range of 21 - 163 mm/h. The most commonly identified pathogen was E. coli (84.9%; 215/253), followed by P. aeruginosa (3.9%; 10/253), K. pneumoniae (4.3%; 11/253), and Enterobacter spp. (2.8%; 7/253). Enterococcus spp. (1.6%; 4/253) and Proteus sp. (1.2%; 3/ 253) were the least frequent isolates in this population.
Antibacterial susceptibility tests showed that the highest resistance rates were related to AMP (71.8%) and SXT (66.3%). In contrast, the most susceptible antibiotics were AK (93.4%) and FT (93.1%). Examination of the trend of resistance pattern over 9 years showed that the sensitivity of AK at 2013-2018 was 93.4%, while at 1994-1998 was 91.4%. However, this antibiotic was the most effective. Between 2013 and 2018, sensitivity to FT was 93.1%, while in 1994-1998, it was 52.9%. Resistance to AMP was 96.4% from 1994-1998, whereas decreased to 71.8% over time (Figure 1 and Table 1).

  Figure 1. A trend of antibiotic susceptibility pattern over time.

  Figure 1. A trend of antibiotic susceptibility pattern over time.

 

However, there was no significant difference between the trend of antibiotic-resistant rate between the first and second periods of study (P>0.05). Only gram-negative isolates demonstrated increased resistance to NA in the second period. A trend of antibiotic susceptibility patterns over time has been shown in Figure 1. Moreover, the details of antibiotic susceptibility patterns of Gram-negative isolates recovered from UTIs are presented in Table 1.
 
Table 1. Antibiotic Susceptibility Patterns of Gram-negative Isolates Recovered From UTIs in 2013-2018

Antimicrobials E. coli
N=215 (%)
P. aeruginosa
N=10 (%)
K. pneumoniae
N=9 (%)
Enterobacter
N=7 (%)
Amikacin 11 (5.1) 1 (10) 0 0
Nitrofurantoin 6 (2.8) 9 (90) 1 (11.1) 0
Gentamicin 37 (17.2) 2 (20) 2 (22.2) 3 (42.8)
Ceftizoxime 33 (15.3) 5 (50) 3 (33.3) 2 (28.6)
Ceftriaxone 61 (28.4) 2 (20) 3 (33.3) 3 (42.8)
Nalidixic acid 110 (51.2) 8 (80) 2 (22.2) 5 (71.4)
Co-trimoxazole 133 (61.9) 8 (80) 5 (55.6) 5 (71.4)
Ampicillin 141 (65.6) 9(90) 9 (100)
  1. (71.4)


 

Discussion

The widespread spreading of bacterial isolates with the extensive ability to resist a broad spectrum of antibiotics is a severe challenge for physicians faced with these organisms (11, 12). Therefore, to monitor the clinicians to proper and accurate prescription for prophylaxis purposes, updated and awareness of antimicro­bial susceptibility pattern is necessary (13, 14). Therefore, the present study investigated the etiology of UTIs and bacterial resistance patterns in UTIs of children admitted to the teaching hospital in the two periods of 1994-1998 and 2013-2018. Accordingly, E. coli was the most frequent isolate, followed by P. aeruginosa, K. pneumoniae, Enteroba-cter spp., Enterococcus spp., and Proteus spp (11, 12). In agreement with a previous study performed by Ronald et al., in our study, E. coli with an isolation rate of 85% was the most frequent isolate (15). Moreover, in accordance with our results, Motamedifar et al. from Shiraz city of Iran reported that E. coli (50.6%) was the most common gram-negative isolate, follo-wed by Klebsiella spp. And Enterobacter spp., respect-ively (16). Farajnia et al. reported that E. coli, P. aeruginosa, and Staphylococcus saprophyticus were three prevalent causes of UTIs in patients aged less than 9 years old and older. However, in contrast with our finding, they revealed that S. saprophyticus was among three frequent isolated bacteria in patients(17).
Similar to findings in previous studies performed by Raya et al. (18), Vazouras et al. (8) and Duicu et al. (19), on the same subject, E. coli was the most frequently encountered etiological agent in our research as well. Therefore, the role of E. coli as the predominant causative agent of UTIs was confirmed in most previous studies (20). These variations rely on the type of isolation, type of infection, studied population, and geographical distribution (21).
E. coli with a frequency of 120 (56.1%) cases in the age group of 1 month to 24 months was the most common cause of UTIs in children. However, in our results, the patterns for the commonest etiologic agent of UTIs other than E. coli were similar in different age groups. So, according to the type of bacteria causing the infection, there is no statistically significant difference in children with different age groups. In contrary to our finding, Fesharakinia et al. revealed that there was a significant association between type of microorganism and the age of patients with UTIs, where the most frequent cause of UTIs in all ages was E. coli (75%), followed by Proteus (11%) (22).
The acceptable treatment of UTIs in pediatrics depends on the early identification of infecting etiology and antibiotic susceptibility patterns (23). In this regard, antibiotic susceptibility results showed that the susceptibility rate of AK in the first period of study was 93.4%, while in the second period of study was 91.4%. However, in the second period of study, this antibiotic was the most sensitive and effective; therefore, it seems that the sensitivity rate of AK in the studied population during these two periods has not significantly changed.
Moreover, according to our results, the sensitivity rate of FT was observed to be 93.1%. In contrast, in the previous period, its sensitivity was 52.9%, probably due to the limited use of FT antibiotics. In addition, in the first period of study, the antibiotic resistance of AMP was 96.4%. In the second period of study, its resistance was reduced to 71.8%, which may be due to the reduction in the use of this antibiotic in children.
However, compared to the previous period (1994-1998), the trend susceptibility rate of all antibiotics except NA in the current period (2013-2018) has increased. In 1994, 31.6% of isolates were resistant to NA, while in 2003 reached over 53% were resistant. In a study conducted by Wang et al., uropathogens had a low susceptibility to imipenem (5.74%) and AMC (3.17%), but they had a high level of susceptibility against cefotaxime (71.41%), cefazolin (73.41%), cefuroxime (72.52%), and aztreonam (70.11%) (24).
Furthermore, in the study performed by Duicu et al., the highest rates of antibiotic resistance were related to ampicillin, AMC, TMP/SMX, cefuroxime, and ciprofloxacin, while FT, CRO, AK, and carbapenem were the most effective agents which suggested may be used for the empirical treatment for febrile or complicated UTI in children (19). Antibiotic resistance patterns are usually wildly changing and increasing, mostly due to variation in the geographical area, type of organisms, different mechanisms, and used metho-ds. However, similar to our study, studies from Oman (25), Iran (16), and Lebanon (26) introduced amino-glycosides and carbapenems as the most effective antibiotics against gram-negative isolates obtained from UTIs. This study had the main limitation; the study was only performed in a children's center; therefore, generalization of the results to other regions requires further investigations.


 

Conclusion

According to the present study, the pattern of drug sensitivity has not changed significantly. Recognition and timely detection of antibiotic resistance and the proper use of antibiotics to reduce drug resistance are the most important principles that should be followed when selecting antibiotics. Moreover, the alarmingly high rates of antibiotic resistance in hospitalized children with UTI and the emergence of carbapenemases emphasize that susceptibility testing should be carried out on all clinical isolates.

 

Acknowledgment

None.

 

Ethics approval and consent to participate

This study was also confirmed and permitted by the Ethics Committee of Babol University of Medical Sciences (IR.MUBABOL.HRI.REC.1398.191). These patients were routinely referred to the microbiology laboratory, and a urine sample was taken, and then we only used bacteria isolates obtained from urine culture.

 

Financial Support

The current study was financially supported by the Research Deputy of Babol University of Medical Sciences with the grant code of 724132236.

 

Author's Contributions

HS and MM; designed the study, reviewed the manuscript and edited the final version. FSH, MH, AP, and MeH contributed to designing the study, collected the data, and drafted the manuscript. FSH and MH contributed to designing the study, collected the data, and participated in drafting the manuscript. AP and MeH analyzed the data, reviewed the manuscript, and edited the final version.
 

 

Conflicts of Interest

The authors report no conflicts of interest in this work.


 

Type of Study: Original Research Article | Subject: Medical Bacteriology
Received: 2021/08/14 | Accepted: 2021/12/6 | ePublished: 2022/01/20

References
1. Eremenko R, Barmatz S, Lumelsky N, Colodner R, Strauss M, Alkan Y. Urinary Tract Infection in Outpatient Children and Adolescents: Risk Analysis of Antimicrobial Resistance. Isr Med Assoc J. 2020;22(4):236-40.
2. Leung AKC, Wong AHC, Leung AAM, Hon KL. Urinary Tract Infection in Children. Recent Pat Inflamm Allergy Drug Discov. 2019;13(1):2-18. [DOI:10.2174/1872213X13666181228154940] [PMID] [PMCID]
3. Lee DS, Lee SJ, Choe HS. Community-Acquired Urinary Tract Infection by Escherichia coli in the Era of Antibiotic Resistance. Biomed Res Int. 2018;2018:7656752. [DOI:10.1155/2018/7656752] [PMID] [PMCID]
4. Zorc JJ, Kiddoo DA, Shaw KN. Diagnosis and management of pediatric urinary tract infections. Clin Microbiol Rev. 2005;18(2):417-22. [DOI:10.1128/CMR.18.2.417-422.2005] [PMID] [PMCID]
5. Chishti AS, Maul EC, Nazario RJ, Bennett JS, Kiessling SG. A guideline for the inpatient care of children with pyelonephritis. Ann Saudi Med. 2010;30(5):341-9. [DOI:10.4103/0256-4947.68549] [PMID] [PMCID]
6. Niehues T. The febrile child: diagnosis and treatment. Dtsch Arztebl Int. 2013;110(45):764-73; quiz 74.
7. Gargollo PC, Diamond DA. Therapy insight: What nephrologists need to know about primary vesicoureteral reflux. Nat Clin Pract Nephrol. 2007;3(10):551-63. [DOI:10.1038/ncpneph0610] [PMID]
8. Vazouras K, Velali K, Tassiou I, Anastasiou-Katsiardani A, Athanasopoulou K, Barbouni A, et al. Antibiotic treatment and antimicrobial resistance in children with urinary tract infections. J Glob Antimicrob Resist. 2020;20:4-10. [DOI:10.1016/j.jgar.2019.06.016] [PMID]
9. Kliegman RM, Behrman RE, Jenson HB, Stanton BM. Nelson textbook of pediatrics e-book: Elsevier Health Sciences; 2007.
10. Wayne P. Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing: Twenty-fourth informational supplement, M100-S29. Clin Lab Stand Inst. 2019;39(1).
11. Ahmed SS, Shariq A, Alsalloom AA, Babikir IH, Alhomoud BN. Uropathogens and their antimicrobial resistance patterns: Relationship with urinary tract infections. Int J Health Sci (Qassim). 2019;13(2):48-55.
12. Bazaid AS, Saeed A, Alrashidi A, Alrashidi A, Alshaghdali K, S AH, et al. Antimicrobial Surveillance for Bacterial Uropathogens in Ha'il, Saudi Arabia: A Five-Year Multicenter Retrospective Study. Infect Drug Resist. 2021;14:1455-65. [DOI:10.2147/IDR.S299846] [PMID] [PMCID]
13. Fair RJ, Tor Y. Antibiotics and bacterial resistance in the 21st century. Perspect Medicin Chem. 2014;6:25-64. [DOI:10.4137/PMC.S14459] [PMID] [PMCID]
14. Sedigh Ebrahim-Saraie H, Motamedifar M, Mansury D, Halaji M, Hashemizadeh Z, Ali-Mohammadi Y. Bacterial Etiology and Antibacterial Susceptibility Patterns of Pediatric Bloodstream Infections: A Two Year Study From Nemazee Hospital, Shiraz, Iran. J Compr Pediatr. 2015;7(1):e29929. [DOI:10.17795/compreped-29929]
15. Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. Dis Mon. 2003;49(2):71-82. [DOI:10.1067/mda.2003.8] [PMID]
16. Motamedifar M, Sedigh Ebrahim-Saraie H, Mansury D, Khashei R, Hashemizadeh Z, Rajabi A. Antimicrobial Susceptibility Pattern and Age Dependent Etiology of Urinary Tract Infections in Nemazee Hospital, Shiraz, South-West of Iran. Int J Enteric Pathogen. 2015;3(3). [DOI:10.17795/ijep26931]
17. Farajnia S, Alikhani MY, Ghotaslou R, Naghili B, Nakhlband A. Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran. Int J Infect Dis. 2009;13(2):140-4. [DOI:10.1016/j.ijid.2008.04.014] [PMID]
18. Raya GB, Dhoubhadel BG, Shrestha D, Raya S, Laghu U, Shah A, et al. Multidrug-resistant and extended-spectrum beta-lactamase-producing uropathogens in children in Bhaktapur, Nepal. Trop Med Health. 2020;48(1):65. [DOI:10.1186/s41182-020-00251-6] [PMID] [PMCID]
19. Duicu C, Cozea I, Delean D, Aldea AA, Aldea C. Antibiotic resistance patterns of urinary tract pathogens in children from Central Romania. Exp Ther Med. 2021;22(1):748. [DOI:10.3892/etm.2021.10180] [PMID] [PMCID]
20. Kot B. Antibiotic Resistance Among Uropathogenic Escherichia coli. Pol J Microbiol. 2019;68(4):403-15. [DOI:10.33073/pjm-2019-048] [PMID] [PMCID]
21. Khodabandeh M, Mohammadi M, Abdolsalehi MR, Hasannejad-Bibalan M, Gholami M, Alvandimanesh A, et al. High-Level Aminoglycoside Resistance in Enterococcus Faecalis and Enterococcus Faecium; as a Serious Threat in Hospitals. Infect Disord Drug Targets. 2020;20(2):223-8. [DOI:10.2174/1871526519666181130095954] [PMID]
22. Fesharakinia A, Malekaneh M, Hooshyar H, Aval M, Gandomy-Sany F. The survey of bacterial etiology and their resistance to antibiotics of urinary tract infections in children of Birjand city. Sci J Nurs Midwif Paramed Faculty. 2012;19(2):208-15.
23. Motamedifar M, Zamani K, Hassanzadeh Y, Pashoutan S. Bacterial Etiologies and Antibiotic Susceptibility Pattern of Urinary Tract Infections at the Pediatric Ward of Dastgheib Hospital, Shiraz, Iran: A Three-Year Study (2009 - 2011). Archives of Clinical Infectious Diseases. 2016;11(2):e28973. [DOI:10.5812/archcid.28973]
24. Wang J, He L, Sha J, Zhu H, Huang L, Zhu X, et al. Etiology and antimicrobial resistance patterns in pediatric urinary tract infection. Pediatr Int. 2018;60(5):418-22. [DOI:10.1111/ped.13526] [PMID]
25. Sharef SW, El-Naggari M, Al-Nabhani D, Al Sawai A, Al Muharrmi Z, Elnour I. Incidence of antibiotics resistance among uropathogens in Omani children presenting with a single episode of urinary tract infection. J Infect Public Health. 2015;8(5):458-65. [DOI:10.1016/j.jiph.2015.01.005] [PMID]
26. Hayajneh WA, Hajj A, Hulliel F, Sarkis DK, Irani-Hakimeh N, Kazan L, et al. Susceptibility trends and molecular characterization of Gram-negative bacilli associated with urinary tract and intra-abdominal infections in Jordan and Lebanon: SMART 2011-2013. Int J Infect Dis. 2015;35:56-61. [DOI:10.1016/j.ijid.2015.04.011] [PMID]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Iranian Journal of Medical Microbiology

Designed & Developed by : Yektaweb | Publisher: Farname Inc